London, UK--(Marketwire - October 1, 2007) -


SMITH & NEPHEW ADVANCED WOUND MANAGEMENT APPOINTS PAUL CAMPBELL AS VICE
PRESIDENT OF STRATEGIC MARKETING



Hull, ENG. and Largo, FL, October 1, 2007 -Smith & Nephew's (LSE: SN; NYSE:SNN)
Advanced Wound Management division today announced the appointment of Paul
Campbell as Vice President of Strategic Marketing for its Advanced Wound Care
Strategic Business Unit (SBU).

Campbell joins Smith & Nephew from J&J Medical, where he commenced
his career in regional Territory Management and Marketing Management roles for
ETHICON Sutures followed by a Product Director role, a Franchise Manager role,
European Business Manager for Haemostasis products and latterly as Group
Marketing Director Worldwide for Surgical Meshes. These roles spanned various
geographies, and he has lived and worked in France, Israel, Turkey, the US as
well as the UK.

"Paul has worked in the medical device industry for the last 18 years with
particular focus in Sales and Marketing.  In that time he has gained a broad
range of international experience and has demonstrated success in a number of
senior management positions", commented Roger Teasdale Senior Vice President.

In this role Campbell will report to Roger Teasdale, Senior Vice President of
the Advanced Wound Care SBU.

Campbell holds a Masters in Languages and an MBA from the University of
Edinburgh.



FOR IMMEDIATE RELEASE

Contact: Sidonie Myers

 Smith & Nephew Advanced Wound Management

 + 44 1482 673246



About Smith & Nephew:



Smith & Nephew is a global medical technology business, specialising in
Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy
and Advanced Wound Management products.  Smith & Nephew is a global leader in
arthroscopy and advanced wound management and is one of the leading global
orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives.  The Company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust.  The Company has 9,600 employees
and operates in 31 countries around the world.  Annual sales in 2006 were nearly
$2.8 billion.







                                      ###


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END